Thursday, January 02, 2020 3:02:36 PM
Scotty,
As a long time holder of IMGN I've been extremely frustrated by their failures. However, I still look at where they are, and what I expect for the future, and I remain invested, and even add to my position. I believe the same applies here. It's not where we've been, it's where we're going.
I've not been a long time investors, just roughly a year and a half, and I certainly see the frustrations, but I also see the belief from most investors that the vaccines work. If that is true, the company cannot help but be successful when results are finally released.
Please don't get me wrong, I cannot guarantee the FDA will approve based on the vaccine working, but I believe the least that will occur would be the company partnering it, and the partner paying for whatever the FDA insisted on. Just the partnership would generate success for investors to date, and while an FDA delay would hurt whatever the share price was at that time, I don't believe it would bring it anywhere close to as low as it is today. I'm not predicting such a problem, but over the years I've learned that nothing is guaranteed when it comes to the FDA.
Gary
As a long time holder of IMGN I've been extremely frustrated by their failures. However, I still look at where they are, and what I expect for the future, and I remain invested, and even add to my position. I believe the same applies here. It's not where we've been, it's where we're going.
I've not been a long time investors, just roughly a year and a half, and I certainly see the frustrations, but I also see the belief from most investors that the vaccines work. If that is true, the company cannot help but be successful when results are finally released.
Please don't get me wrong, I cannot guarantee the FDA will approve based on the vaccine working, but I believe the least that will occur would be the company partnering it, and the partner paying for whatever the FDA insisted on. Just the partnership would generate success for investors to date, and while an FDA delay would hurt whatever the share price was at that time, I don't believe it would bring it anywhere close to as low as it is today. I'm not predicting such a problem, but over the years I've learned that nothing is guaranteed when it comes to the FDA.
Gary
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
